Accessibility Menu
Solventum logo

Solventum(NYSE) SOLV

Market Cap$14.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+8%
5 YearN/A
1 Year+17%
1 Month+8%
$88.57
+2.79%
+2.40Today
Solventum last closing stock price
MetricPriceDate
Last closeUSD 86.172026-07-28
Solventum stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.63%USD 78.602026-07-21
1 month+8.35%USD 79.532026-06-26
3 month+29.6%USD 66.492026-04-29
Year to date+8.75%USD 79.242025-12-31
1 year+16.81%USD 73.772025-07-28
Since inception+7.71%USD 80.002024-03-26

Solventum Financials at a Glance

Market Cap

$14.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.26B

Net Income (TTM)

$1.43B

EPS (TTM)

$8.16

P/E Ratio

10.55

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$88.57

Volume

1,756,613.664

Open

$86.10

Previous Close

$86.17

Daily Range

$85.88 - $88.65

52-Week Range

$62.38 - $88.65

Estimated Earnings Date

Aug 5, 2026

SOLV News

GettyImages-941740978-1201x801-d21b45d

The Largest Healthcare Companies by Market Cap in July 2026

Lyle DalyJul 7, 2026
Foolcom-Featured.png

Solventum (SOLV) Fiscal Q2 EPS Jumps 8%

Motley Fool Markets TeamAug 7, 2025
GettyImages-1493870747-600x400-bf06395.jpg

Solventum: Q4 EPS Beats, Cash Flow Dips

Motley Fool Markets TeamFeb 28, 2025

SOLV: Motley Fool Moneyball Superscore

56

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Solventum

Solventum makes products that help doctors and nurses care for patients in hospitals and clinics. Its tools help heal wounds, clean water for medical use, and manage dental work. The company also creates software that helps health systems organize their digital records and billing.

The Healthcare Portfolio

  • MedSurg: Advanced wound dressings, stethoscopes, and surgical supplies designed to prevent infections; represented 57.9% of total sales in 2025.
  • Dental Solutions: Brackets, aligners, and restorative cements used by dentists to fix and protect teeth; accounted for 16.2% of total sales in 2025.
  • Health Information Systems: Software that uses speech recognition and data tools to help clinicians document patient care; contributed 16.3% of total sales in 2025.
  • Purification and Filtration: Technology used to filter fluids and gases in medical and industrial settings.

Growth and Changing Hands

  • Completed the spin-off from 3M on April 1, 2024, to become an independent public company.
  • Acquired Acera Surgical in 2025, a bioscience firm specializing in synthetic tissue materials.
  • Sold the Purification and Filtration business to Thermo Fischer Scientific in 2025 to streamline the portfolio.
  • Repaid a portion of its debt in 2025 using the money earned from the sale of its filtration segment.

What Makes Solventum Stand Out

The company relies on a global network to sell its products in over 90 countries. Its innovation is supported by approximately 2,000 research and development employees who hold thousands of patents for medical and dental technologies.

Measuring Recent Success

  • Operating income rose to $1.7 billion in Q4 2025, up 1133.8% from $136 million in Q4 2024.
  • Net income grew to $63 million in Q4 2025, a 103.2% increase over the previous year.
  • Revenue reached $2 billion in Q4 2025, representing a 3.7% decrease compared to Q4 2024.
  • Free cash flow was $32 million in Q4 2025, down 65.2% from $92 million in the prior year.

The Bottom Line

Solventum has transitioned from a division of a larger conglomerate into a focused healthcare entity. Its strategy centers on combining material science with digital software to improve how medical professionals treat patients globally.

AI Generated • Apr 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

20,000

CEO

Bryan C. Hanson

Website

www.solventum.com

Headquarters

Eagan, MN 55121, US

SOLV Financials

Key Financial Metrics (TTM)

Gross Margin

53.67%

Operating Margin

25.54%

Net Income Margin

17.33%

Return on Equity

30.71%

Return on Capital

21.63%

Return on Assets

10.16%

Earnings Yield

9.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

173.18M

Volume

1.76M

Avg. Volume

1.69M

Financials (TTM)

Gross Profit

$4.43B

Operating Income

$2.11B

EBITDA

$2.75B

Operating Cash Flow

$151.00M

Capital Expenditure

-$354.00M

Free Cash Flow

-$203.00M

Cash & ST Invst.

$561.00M

Total Debt

$5.08B

Solventum Performance Analysis

Solventum annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 8,130,000,000-0.5%
20232023-12-31USD 8,197,000,0000.8%
20242024-12-31USD 8,254,000,0000.7%
20252025-12-31USD 8,325,000,0000.9%
Solventum sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-304.4%
Q32025-09-30-3.0%
Q42025-12-31-4.7%
Q12026-03-310.5%
Solventum annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 7.78-8.0%
20232023-12-31USD 7.790.2%
20242024-12-31USD 2.76-64.6%
20252025-12-31USD 8.88221.9%
Solventum sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-34.6%
Q32025-09-301315.7%
Q42025-12-31-94.9%
Q12026-03-31-81.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.01B

-3.0%

Gross Profit

$1.10B

-1.5%

Gross Margin

54.66%

N/A

Market Cap

$14.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$746.12K

N/A

Employees

20,000

N/A

Net Income

$13.00M

-90.5%

EBITDA

$213.00M

-21.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$561.00M

+5.1%

Total Debt

$5.08B

-35.8%

Accounts Receivable

$1.06B

-4.7%

Inventory

$1.09B

+25.8%

Long Term Debt

$4.58B

-41.4%

Short Term Debt

$505.00M

+405.0%

Return on Assets

10.16%

N/A

Return on Invested Capital

19.63%

N/A

Free Cash Flow

-$273.00M

-241.3%

Operating Cash Flow

-$189.00M

-751.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICLRICON Public Limited Company
$178.18-1.14%
ELANElanco Animal Health Incorporated
$26.39+3.41%
ALGNAlign Technology, Inc.
$180.08+2.55%
RVTYRevvity, Inc.
$113.37+1.67%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.23-0.09%
NVDANvidia
$190.01-0.04%
INTCIntel
$81.92-0.05%
FFord Motor Company
$15.28+0.02%

Questions About SOLV

What is the current price of Solventum?

Solventum is trading at $88.55 per share.

What is the 52-week range for Solventum?

Over the past 52 weeks, Solventum has traded between $62.38 and $88.65.

How much debt does Solventum have?

As of the most recent reporting period, Solventum reported total debt of $5.29B.

How much cash does Solventum have on hand?

Solventum reported $561.00M in cash and cash equivalents in its most recent financial results.

What is Solventum’s dividend yield?

Solventum does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services